Your browser doesn't support javascript.
loading
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer.
Guo, Zhaorong; Tada, Hiroshi; Kitamura, Narufumi; Hamada, Yoh; Miyashita, Minoru; Harada-Shoji, Narumi; Sato, Akiko; Hamanaka, Yohei; Tsuboi, Kouki; Harada, Nobuhisa; Takano-Kasuya, Mayumi; Okada, Hisatake; Nakano, Yasushi; Ohuchi, Noriaki; Hayashi, Shin-Ichi; Ishida, Takanori; Gonda, Kohsuke.
Afiliación
  • Guo Z; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. guozhaorong1@yahoo.co.jp.
  • Tada H; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. hiroshi-tada@med.tohoku.ac.jp.
  • Kitamura N; Department of Medical Physics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. n-kitamura@med.tohoku.ac.jp.
  • Hamada Y; Department of Medical Physics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. yhamada@med.tohoku.ac.jp.
  • Miyashita M; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. atihsayim8m8@med.tohoku.ac.jp.
  • Harada-Shoji N; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. vecchio03@yahoo.co.jp.
  • Sato A; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. aki_aki_tan@yahoo.co.jp.
  • Hamanaka Y; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. h-y@med.tohoku.ac.jp.
  • Tsuboi K; Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. k.tsuboi@med.tohoku.ac.jp.
  • Harada N; Bio Systems Development Group, Bio Advanced Technology Division, Corporate R&D Headquarters, KONICA MINOLTA, INC., Hino, Tokyo 191-8511, Japan. nobuhisa.harada@konicaminolta.com.
  • Takano-Kasuya M; Department of Medical Physics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. takano@med.tohoku.ac.jp.
  • Okada H; Bio Systems Development Group, Bio Advanced Technology Division, Corporate R&D Headquarters, KONICA MINOLTA, INC., Hino, Tokyo 191-8511, Japan. hisatake.okada@konicaminolta.com.
  • Nakano Y; Bio Systems Development Group, Bio Advanced Technology Division, Corporate R&D Headquarters, KONICA MINOLTA, INC., Hino, Tokyo 191-8511, Japan. yasushi.nakano@konicaminolta.com.
  • Ohuchi N; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. noriaki-ohuchi@med.tohoku.ac.jp.
  • Hayashi SI; Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. shin@med.tohoku.ac.jp.
  • Ishida T; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. takanori@med.tohoku.ac.jp.
  • Gonda K; Department of Medical Physics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan. gonda@med.tohoku.ac.jp.
Cancers (Basel) ; 11(4)2019 Apr 12.
Article en En | MEDLINE | ID: mdl-31013810

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Japón